Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease, and the long-term survival varies with different ages. We performed a retrospective analysis of 122 newly diagnosed adults with standard-risk ALL treated with Escherichia coli asparaginase (E. coli-asparaginase, n = 50) and polyethylene...
Main Authors: | Liu, Wen-jian, Wang, Hua, Wang, Wei-da, Zhu, Meng-yuan, Liu, Cheng-cheng, Wang, Jing-hua, Lu, Yue |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175128/ |
Similar Items
-
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
by: Vrooman, Lynda M., et al.
Published: (2015) -
L-Asparaginase induced thrombosis in acute lymphoblastic leukemia
by: Kulkarni, Ketan P.
Published: (2012) -
Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
by: Hijiya, Nobuko, et al.
Published: (2016) -
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
by: Egler, Rachel A., et al.
Published: (2016) -
Rhizobium etli asparaginase II: An alternative for acute lymphoblastic leukemia (ALL) treatment
by: Huerta-Saquero, Alejandro, et al.
Published: (2013)